{
    "nctId": "NCT01089049",
    "briefTitle": "Effect of a Natural Health Product on Urinary Estrogen Metabolites",
    "officialTitle": "A Clinical Trial to Assess the Efficacy of a Supplemental Formula Targeting Breast Health in Beneficially Altering Urinary Estrogen Metabolites Levels in Both Pre- and Post-menopausal Women",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 98,
    "primaryOutcomeMeasure": "2-OH Hydroxy Estrone: 16-alpha-OH Estrone",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 years of age or older\n* Healthy\n* Willing to collect urine samples and to have blood drawn\n* Post-menopausal and have not taken hormone replacement therapy (HRT) in the past year (48 subjects)\n* Pre-menopausal (48 subjects)\n\nExclusion Criteria:\n\n* Diagnosed with any major illness(e.g. cancer)\n* Diabetes, thyroid disease, atypical hyperplasia, fibrocystic breast disease, family history of ovarian cancer, a history of \"migraines with aura\"\n* Women taking blood thinner or thyroid medication (including warfarin)\n* Known allergy to any of the any of the study ingredients\n* Pregnancy or lactation\n* Regular consumption in the previous 3 months of any other natural health products (NHPs) or pharmaceutical containing ingredients with a similar effect on estrogen metabolism as those included in the femMED Breast Health treatment\n* Family history of breast cancer risk\n* Post-menopausal women on HRT\n* Pre-menopausal women taking hormonal contraceptives (oral contraceptives, the patch etc.)\n* All other forms of estrogen, progesterone and/or androgens (i.e. testosterone therapy)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}